|
Contents
|
|
|
|
Glioblastoma
|
 
|
|
|
|
Affronti
ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh
JJ, Friedman AH, Bigner DD, Friedman HS
Overall
survival of newly diagnosed glioblastoma patients receiving carmustine
wafers followed by radiation and concurrent temozolomide plus rotational
multiagent chemotherapy
Cancer. 2009 Jun 9. [Epub
ahead of print]
.JPG)
Abstract
|
|
|
Aoki H, Yokoyama T, Fujiwara K, Tari AM, Sawaya
R, Suki D, Hess KR, Aldape KD, Kondo S, Kumar R, Kondo Y.
Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter
Survival Time in Patients with Glioblastoma.
Clin
Cancer Res. 2007 Nov 15;13(22):6603-6609.
Abstract
|
|
|
Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia
A, Voulgaris S, Fotopoulos AD.
The
Value of 99mTc-Tetrofosmin Brain SPECT in Predicting Survival in Patients
with Glioblastoma Multiforme.
J
Nucl Med. 2010 Dec;51(12):1923-6. Epub 2010 Nov 15.
Abstract |
.png)
Reprint |
.gif)
Related articles
|
|
|
G. L. Banna, R. Pallini, L. Ricci-Vitiani, M.
Signore, D. Lombardi, M. Martini, G. Maira, D. Giuffrida, L. M. Larocca, and
R. De Maria
High prognostic potential of glioblastoma
stem
cell analysis
ASCO Meeting Abstracts, Jun 2007; 25: 10580
Abstract
|
|
|
Bähr
O, Herrlinger U, Weller M, Steinbach JP.
Very late relapses in glioblastoma long-term survivors
J Neurol. 2009 May 12;. [Epub ahead of print]
Abstract
|
|
Barker
FG 2nd, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK,
McDermott MW, Sneed PK, Wara WM, Wilson CB.
Radiation
response and survival time in patients with glioblastoma multiforme
J Neurosurg 1996
Mar;84(3):442-8
|
|
Barker
FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB
Survival
and functional status after resection of recurrent glioblastoma multiforme
Neurosurgery. 1998 Apr;42(4):709-20
|
|
J.L.
Blanc, M. Wager, J. Guilhot, S. Kusy, B. Bataille, T. Chantereau, F.
Lapierre, C.J. Larsen, L. Karayan-Tapon
Correlation of
Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas
Journal of Neuro-Oncology, 68 (3): 275-283, July 2004. (Abstract+)
|
|
|
Blumenthal
DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM, Rogers CL, Corn BW.
Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients
With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology
Group Database
J Clin Oncol. 2008 Dec 29; [Epub ahead of print]
Abstract
|
|
|
Brandes
AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R,
Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F,
Ermani M.
MGMT promoter methylation status can predict the incidence and outcome of
pseudoprogression after concomitant radiochemotherapy in newly diagnosed
glioblastoma patients
J
Clin Oncol. 2008 May 1;26(13):2192-7
Abstract |
.png) Full Text |
Reprint
|
|
L.
Butttolo, F. Giunta, V. D. Ferrari, G. Marini
Temozolomide
in glioblastoma: 4 years' experience with monthly or fortnigthly schedule
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 437
|
|
|
Chaichana KL, McGirt MJ, Frazier J, Attenello F,
Guerrero-Cazares H, Quinones-Hinojosa
A.
Relationship of glioblastoma multiforme to the lateral ventricles
predicts survival following tumor resection
J Neurooncol.
2008 May 6. [Epub ahead of print]
Abstract
|
|
|
Chan DT, Kam MK, Ma BB, Ng SC, Pang JC, Lau CK, Siu DY, Ng BS, Zhu XL, Chen
GG, Ng HK, Poon WS.
Association
of molecular marker O(6)Methylguanine DNA methyltransferase and concomitant
chemoradiotherapy with survival in Southern Chinese glioblastoma patients.
Hong
Kong Med J. 2011 Jun;17(3):184-8.
Abstract |
Reprint |
Related articles
|
|
|
Chinnaiyan P, Wang M, Rojiani AM, Tofilon PJ,
Chakravarti A, Ang KK, Zhang HZ, Hammond E, Curran W Jr, Mehta MP.
The prognostic value of nestin expression in newly diagnosed
glioblastoma: report from the Radiation Therapy Oncology Group
Radiat Oncol. 2008 Sep 25;3:32
Abstract |
Full Text |
Reprint
|
|
A. K. Choucair, W. Seiferheld, C. Ford, J. Hansen, B. Dabbas, C. Schultz, A.
Schulsinger, M. Mehta, W. Curran
Long term survivors with glioblastoma multiforme
(GBM) treated on RTOG protocols with irradiation and nitrosurea have higher
initial expression of Ki-67
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9661
|
|
|
Crawford FW, Khayal IS, McGue C, Saraswathy S,
Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ.
Relationship of pre-surgery metabolic and physiological MR imaging
parameters to survival for patients with untreated GBM
J Neurooncol. 2008 Nov 15; [Epub ahead of print]
Abstract
|
|
|
Darefsky AS, King JT Jr,
Dubrow R.
Adult
glioblastoma multiforme survival in the temozolomide era: A population-based
analysis of surveillance, epidemiology, and end results registries.
Cancer. 2011 Aug 31.
[Epub ahead of print]
Abstract |
Related articles
|
|
|
Donato
V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R
Prognostic
implication of clinical and pathologic features in patients with
glioblastoma multiforme treated with concomitant radiation plus temozolomide
Tumori. 2007 May-Jun;93(3):248-56
Abstract |
Reprint
|
|
|
Eoli M, Menghi F, Bruzzone MG, De Simone T,
Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L,
Filippini G, Broggi G, Boiardi A, Finocchiaro G.
Methylation of O6-methylguanine DNA methyltransferase and loss of
heterozygosity on 19q and/or 17p are overlapping features of secondary
glioblastomas with prolonged survival
Clin
Cancer Res. 2007 May 1;13(9):2606-13
Abstract |
Full Text |
Reprint
|
|
|
Erpolat
OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber S
Outcome of newly diagnosed glioblastoma patients treated by radiotherapy
plus concomitant and adjuvant temozolomide: a long-term analysis
Tumori. 2009 Mar-Apr;95(2):191-7
Abstract
|
|
|
Evans
SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins
AR, Grady MS, Hahn SM, Koch CJ
The Relationship among Hypoxia, Proliferation, and Outcome in Patients with
De Novo Glioblastoma: A Pilot Study
Transl Oncol. 2010 Jun 1;3(3):160-9
Abstract |
Full Text |
Reprint
|
|
|
Filippini G, Falcone C, Boiardi A, Broggi G,
Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G,
Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG.
Prognostic factors for survival in 676 consecutive patients with newly
diagnosed primary glioblastoma.
Neuro Oncol. 2007 Nov 9;. [Epub ahead of print]
Abstract
|
|
|
Fischer Jde S, Carvalho PC, Neves-Ferreira AG,
da Fonseca CO, Perales J, Carvalho Mda G, Domont GB.
Anti-thrombin as a prognostic biomarker candidate for patients with
recurrent glioblastoma multiform under treatment with perillyl alcohol
J Exp Ther Oncol. 2008;7(4):285-90
Abstract
|
|
C. Ford, W. Seiferheld, A. K. Choucair, J. Hansen, B. Dabbas, C. Schultz, A.
Schulsinger, M. Mehta, W. Curran
Evaluation of expression of
DNA repair molecules as a prognostic factor for long-term survivors with
glioblastoma multiforme (GBM) treated on RTOG protocols with irradiation and
nitrosoureas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1509
|
|
Gamburg ES, Regine
WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB.
The
prognostic significance of midline shift at presentation on survival in patients
with glioblastoma multiforme
Int J Radiat Oncol Biol Phys 2000 Dec 1;48(5):1359-62
|
|
|
Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff
RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier
A, Lacombe D, Stupp R
Nomograms for predicting survival of patients with newly diagnosed
glioblastoma: prognostic factor analysis of EORTC and NCIC trial
26981-22981/CE.3
Lancet Oncol. 2007 Dec 12; [Epub ahead of print]
Abstract
|
|
T. Gorlia, R. Stupp, E. A. Eisenhauer, R. O.
Mirimanoff, M. J. Van Den Bent, K. Belanger, D. Lacombe, A. Allgeier, European Organisation for Research and Treatment of Cancer
(EORTC)
Brain And Radiotherapy Groups, National Cancer Institute of Canada (NCIC)
Clinical Trials Group
Clinical prognostic factors affecting survival in
patients with newly diagnosed Glioblastoma Multiforme (GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9599
|
|
|
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB,
Rosenfeld M, Fisher J.
Survival of patients with newly diagnosed glioblastoma treated with
radiation and temozolomide in research studies in the United States
Clin Cancer Res. 2010 Apr 15;16(8):2443-9
Abstract
|
|
Hakin-Smith
V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR,
Royds JA
Alternative
lengthening of telomeres and survival in patients with glioblastoma multiforme
Lancet 2003 Mar 8;361(9360):836-8
|
|
Monika E. Hegi, Ph.D.,
Annie-Claire Diserens, M.Sc., Thierry Gorlia, M.Sc., Marie-France Hamou,
Nicolas de Tribolet, M.D., Michael Weller, M.D., Johan M. Kros, M.D.,
Johannes A. Hainfellner, M.D., Warren Mason, M.D., Luigi Mariani, M.D.,
Jacoline E.C. Bromberg, M.D., Peter Hau, M.D., René O. Mirimanoff, M.D.,
J. Gregory Cairncross, M.D., Robert C. Janzer, M.D., and Roger Stupp, M.D.
MGMT
Gene Silencing and Benefit from Temozolomide in Glioblastoma
The New England Journal of Medicine,
Volume 352:997-1003, Number 10, March 10, 2005
|
|
Monika E.
Hegi,
Annie-Claire Diserens, Sophie Godard,
Pierre-Yves Dietrich, Luca Regli,
Sandrine Ostermann, Philippe Otten,
Guy Van Melle, Nicolas de Tribolet
and Roger Stupp
Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA
Methyltransferase Promoter Methylation in Glioblastoma Patients
Treated with Temozolomide
Clinical Cancer Research Vol. 10, 1871-1874, 15 March 2004
|
|
|
Helseth
R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, Scheie D, Vik
A, Meling TR.
Overall survival, prognostic factors, and repeated surgery in a
consecutive series of 516 patients with glioblastoma multiforme
Acta Neurol Scand. 2010 Mar 18;. [Epub ahead of print]
Abstract
|
|
|
Hottinger AF, Yoon H, Deangelis LM, Abrey LE
Neurological
outcome of long-term glioblastoma survivors
J Neurooncol.
2009 Jun 26. [Epub ahead of print]
Abstract
|
|
|
Hulleman E, Quarto M, Vernell R, Masserdotti G,
Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Rodriguez Y
Baena R, Capra M, Helin K.
A role for the transcription factor HEY1 in glioblastoma
J Cell Mol Med. 2008 Mar 17; [Epub ahead of print]
Abstract |
Reprint
|
|
|
Hutterer M
Elderly Patients with Glioblastoma Multiforme - An Underestimated
Subpopulation?
Neuroepidemiology. 2009 Mar 27;33(1):23-24. [Epub ahead of print]°
Abstract |
Reprint
|
|
|
Johnson
DR, O'Neill BP.
Glioblastoma survival in the United States before and during the
temozolomide era.
J Neurooncol. 2011 Nov 2;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Kawabata
S, Miyatake SI, Nonoguchi N, Hiramatsu R, Iida K, Miyata S, Yokoyama K, Doi
A, Kuroda Y, Kuroiwa T, Michiue H, Kumada H, Kirihata M, Imahori Y,
Maruhashi A, Sakurai Y, Suzuki M, Masunaga SI, Ono K
Survival benefit from boron neutron capture therapy for the newly diagnosed
glioblastoma patients
Appl Radiat Isot. 2009 Mar 25;. [Epub ahead of print]
Abstract
|
|
Keles GE, Lamborn KR, Chang SM, Prados
MD, Berger MS
Volume of residual disease as a predictor of
outcome in adult patients with recurrent supratentorial glioblastomas
multiforme who are undergoing chemotherapy
J Neurosurg. 2004 Jan;100(1):41-6
|
|
|
Kita
D, Ciernik IF, Vaccarella S, Franceschi S, Kleihues P, Lütolf UM, Ohgaki
H.
Age as a Predictive Factor in Glioblastomas: Population-Based Study
Neuroepidemiology. 2009 Mar 27;33(1):17-22. [Epub ahead of print]
Abstract
|
|
B. K. Kleinschmidt-DeMasters, MD; K. O.
Lillehei, MD; M. Varella-Garcia, PhD
Glioblastomas in the Older
Old
Arch
Pathol Lab Med. 2005 May;129(5):624-631
|
|
Koka V, Potti A, Forseen SE, Pervez H,
Fraiman GN, Koch M, Levitt R
Role
of her-2/neu overexpression and clinical determinants of early mortality
in glioblastoma multiforme
Am J Clin Oncol.
2003 Aug;26(4):332-5
|
|
H. Kobayashi, N. Ishii, J. Ikeda,
Y. Sawamura, Y. Iwasaki
Methylation
profiling of the DNA repair genes in glioblastoma multiforme and its clinical
relevance
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1572
|
|
Kraus JA,
Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete
S, Dietzmann K, Muller B, Heuser K, Reifenberger G, Schlegel U
Long-term
survival of glioblastoma multiforme: importance of histopathological
reevaluation
J Neurol. 2000
Jun;247(6):455-60
|
|
|
Kong DS, Song SY, Kim DH, Joo KM, Yoo JS, Koh
JS, Dong SM, Suh YL, Lee JI, Park K, Kim JH, Nam DH
Prognostic significance of c-Met expression in glioblastomas
Cancer. 2008 Oct 30. [Epub
ahead of print]
Abstract
|
|
|
Krex
D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M,
Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G; German Glioma
Network
Long-term survival with glioblastoma multiforme
Brain.
2007 Oct;130(Pt 10):2596-606. Epub 2007 Sep 4
Abstract
|
Full
Text |
Reprint
|
|
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F,
Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller
D, Sawaya R
A
multivariate analysis of 416 patients with glioblastoma multiforme:
prognosis, extent of resection, and survival
J Neurosurg. 2001
Aug;95(2):190-8
|
|
Kathleen R. Lamborn, Susan M.
Chang, Michael D. Prados
Prognostic factors for survival of patients with glioblastoma: Recursive
partitioning analysis
Neuro-Oncology, Vol. 6, No. 3, July
2004, 227 -- 235. (Abstract+)
|
|
|
Lawrence
YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X,
Symon Z, Dicker AP.
Improving prognosis of
glioblastoma in the 21st century: Who has benefited most?
Cancer. 2011 Dec 16;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Leif G. Salford, Erik Nordenström, Gunnar Skagerberg, Torgil Möller,
Bengt Widegren, and Roland Perfekt
Women with Left Frontal Glioblastoma Have a Significantly Shorter
Survival—Why?
Neuro-oncol 2006; 8(4): 290-291; first published on August 31, 2006 as DOI:
10.1215/15228517-2006-017
Full
Text |
Reprint
|
|
|
Li S, Zhang W, Chen B, Jiang T, Wang Z
Prognostic and predictive value of p53 in low MGMT expressing
glioblastoma treated with surgery, radiation and adjuvant temozolomide
chemotherapy
Neurol Res.
2009 Aug 21. [Epub ahead of print]
Abstract
|
|
|
Li
SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, Jiang T
Prognostic factors influencing clinical outcomes of glioblastoma multiforme
Chin Med J (Engl). 2009 Jun 5;122(11):1245-9
Abstract |
Full Text |
Reprint
|
|
|
Li S, Jiang T, Li G, Wang Z
Impact of p53 status to response of temozolomide in low MGMT expression
glioblastomas: preliminary results
Neurol Res.
2008 Jul;30(6):567-70
Abstract
|
|
|
Daniel A. Lim, Soonmee Cha,
Mary C. Mayo, Mei-Hsiu Chen, Evren Keles,
Scott VandenBerg and Mitchel S. Berger
Relationship of glioblastoma multiforme to neural stem cell regions
predicts invasive and multifocal tumor phenotype
Neuro Oncol 2007 Oct 1. 9(4):424-429; DOI:10.1215/15228517-2007-023. First
published on July 10, 2007
Abstract
|
Full
Text |
Reprint
|
|
|
Mangla R, Singh G, Ziegelitz D, Milano MT, Korones DN, Zhong
J, Ekholm SE
Changes in Relative Cerebral Blood Volume 1 Month after
Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients
with Glioblastoma
Radiology. 2010 Jun 7;. [Epub ahead of print]
Abstract
|
|
|
Matsuda
M, Yamamoto T, Kumada H, Nakai K, Shirakawa M, Tsurubuchi T, Matsumura A
Dose distribution and clinical response of glioblastoma treated with boron
neutron capture therapy
Appl Radiat Isot. 2009 Mar 27;. [Epub ahead of print]
Abstract
|
|
|
Matsumura
A, Yamamoto T, Tsurubuchi T, Matsuda M, Shirakawa M, Nakai K, Endo K, Tokuue
K, Tsuboi K.
Current practices and future directions of therapeutic strategy in
glioblastoma: Survival benefit and indication of BNCT
Appl Radiat Isot. 2009 Mar 24;. [Epub ahead of print]
Abstract
|
|
|
McGirt MJ, Mukherjee D, Chaichana KL, Than KD,
Weingart JD, Quinones-Hinojosa A.
Association of surgically acquired motor and language deficits on overall
survival after resection of glioblastoma multiforme
Neurosurgery. 2009 Sep;65(3):463-9; discussion 469-70
Abstract
|
|
|
McLendon
RE, Halperin EC
Is the long-term survival of patients with intracranial glioblastoma
multiforme overstated?
Cancer. 2003 Oct
15;98(8):1745-8. Published Online: 26 Aug 2003
Abstract |
Full Text |
Reprint
|
|
|
Mellai M, Caldera V, Annovazzi L, Chiò
A, Lanotte M, Cassoni P, Finocchiaro G, Schiffer D
MGMT Promoter Hypermethylation in a Series of 104 Glioblastomas
Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):219-27
Abstract
|
|
|
Milano
MT, Okunieff P, Donatello RS, Mohile NA, Sul J, Walter KA, Korones DN.
Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation
for Glioblastoma
Int J Radiat Oncol Biol Phys. 2010 Mar 6;. [Epub ahead of print]
Abstract
|
|
|
Miyatake
SI, Kawabata S, Yokoyama K, Kuroiwa T, Michiue H, Sakurai Y, Kumada H,
Suzuki M, Maruhashi A, Kirihata M, Onoc K
Survival benefit of boron neutron capture therapy for recurrent malignant
gliomas
Appl Radiat Isot. 2009 Mar 27;. [Epub ahead of print]
Abstract
|
|
|
Mueller S, Polley MY, Lee B, Kunwar S, Pedain C, Wembacher-Schröder E,
Mittermeyer S, Westphal M, Sampson JH, Vogelbaum MA, Croteau D, Chang SM.
Effect
of imaging and catheter characteristics on clinical outcome for patients in
the PRECISE study.
J Neurooncol.
2011 Jan;101(2):267-77. Epub 2010 Jun 20.
Abstract |
Reprint |
Related articles
|
|
Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller
GN,
Wildrick DM, Sawaya R
Cystic glioblastoma multiforme: survival outcomes in
22 cases
J Neurosurg. 2004 Jan;100(1):61-7
|
|
|
Mangiola A, de Bonis P, Maira G, Balducci M,
Sica G, Lama G, Lauriola L, Anile C
Invasive tumor cells and prognosis in a selected population of patients
with glioblastoma multiforme
Cancer. 2008 Jul 10; [Epub ahead of print]
Abstract
|
|
|
Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C,
Lauriola L, La Torre G, Sabatino G, Maira G, Jhanwar-Uniyal M, Sica G
Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and
Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications
Clin
Cancer Res. 2007 Dec 1;13(23):6970-6977.
Abstract
|
|
|
Marchan EM, Sekula RF Jr, Jannetta PJ, Quigley
MR
Long-term survival enhanced by cordectomy in a patient with a spinal
glioblastoma multiforme and paraplegia. Case report
J Neurosurg Spine. 2007 Dec;7(6):656-9
Abstract
|
|
|
Marina
O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH,
Elinzano H, Chao ST.
Treatment outcomes for patients
with glioblastoma multiforme and a low Karnofsky Performance Scale score on
presentation to a tertiary care institution.
J Neurosurg. 2011 May 6;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Ramon Martinez, Gabriele Schackert and
Manel Esteller
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic
importance in glioblastoma multiforme
J Neurooncol. 2006 Oct 18; [Epub
ahead of print]
Abstract
|
|
|
Mauer
M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, de Witte O,
Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller
M, Bottomley A.
The prognostic value of health-related quality-of-life data in predicting
survival in glioblastoma cancer patients: results from an international
randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and
NCIC Clinical Trials Group study.
Br J Cancer.
2007 Jul 3; [Epub ahead of print]
PMID: 17609661 [PubMed - as supplied by publisher]
|
|
|
McLendon
RE, Halperin EC
Is the long-term survival of patients with intracranial glioblastoma
multiforme overstated?
Cancer. 2003 Oct
15;98(8):1745-8. Published Online: 26 Aug 2003
Abstract |
Full Text |
Reprint
|
|
|
Park CK, Park SH, Lee SH, Kim CY, Kim DW, Paek
SH, Kim DG, Heo DS, Kim IH, Jung
HW
Methylation status of the MGMT gene promoter fails to predict the clinical
outcome of glioblastoma patients treated with ACNU plus cisplatin
Neuropathology. 2009 Jan 6. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
Parsa AT, Wachhorst S, Lamborn KR, Prados
MD, McDermott MW, Berger MS,
Chang SM
Prognostic significance of intracranial dissemination of
glioblastoma multiforme in adults
J
Neurosurg. 2005 Apr;102(4):622-8
|
|
|
Piroth
MD, Pinkawa M, Holy R, Klotz J, Nussen S, Stoffels G, Coenen HH, Kaiser HJ,
Langen KJ, Eble MJ
Prognostic
Value of Early [(18)F]Fluoroethyltyrosine Positron Emission Tomography After
Radiochemotherapy in Glioblastoma Multiforme
Int
J Radiat Oncol Biol Phys. 2010 Jun 18. [Epub ahead of print]
Abstract
|
|
|
Pirzkall A, McGue C, Saraswathy S, Cha S, Liu R,
Vandenberg S, Lamborn KR, Berger MS, Chang SM, Nelson SJ.
Tumor regrowth between surgery and initiation of adjuvant therapy in
patients with newly diagnosed glioblastoma
Neuro Oncol. 2009 Feb 19; [Epub ahead of print]
Abstract
|
|
|
Puzzilli
F, Ruggeri A, Mastronardi L, Di Stefano D, Lunardi P
Long-term survival in cerebral glioblastoma. Case report and critical
review of the literature
Tumori. 1998 Jan-Feb;84(1):69-74
Abstract
|
|
|
Pichlmeier U, Bink A, Schackert G, Stummer W,
Study Group AG.
Resection and survival in glioblastoma multiforme: An RTOG recursive
partitioning analysis of ALA study patients
Neuro Oncol. 2008 Jul 30; [Epub ahead of print]
Abstract
|
|
|
Ruano Y, Mollejo M, Camacho FI, de Lope AR, Fiaño
C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B
Identification of survival-related genes of the phosphatidylinositol
3'-kinase signaling pathway in glioblastoma multiforme
Cancer. 2008 Feb 7; [Epub
ahead of print]
Abstract
|
|
|
Ruano Y, Ribalta T, de Lope AR, Campos-Martín
Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B
Worse outcome in primary glioblastoma multiforme with concurrent epidermal
growth factor receptor and p53 alteration
Am J Clin Pathol. 2009 Feb;131(2):257-63
Abstract |
Full Text |
Reprint
|
|
Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F,
Arifin MT, Arita K, Kurisu K.
Prognosis of cerebellar glioblastomas: correlation between prognosis and
immunoreactivity for epidermal growth factor receptor compared with
supratentorial glioblastomas.
Anticancer Res. 2006 Mar-Apr;26(2B):1351-7.
Abstract
|
|
|
Salvati
M, Formichella AI, D'Elia A, Brogna C, Frati A, Giangaspero F, Delfini R,
Santoro A
Cerebral
glioblastoma with oligodendrogliomal component: analysis of 36 cases
J Neurooncol.
2009 Apr 3. [Epub ahead of print]
Abstract
|
|
|
Salvati
M, Cervoni L, Artico M, Caruso R, Gagliardi FM
Long-term survival in patients with supratentorial glioblastoma
J Neurooncol.
1998 Jan;36(1):61-4
Abstract |
Reprint
|
|
|
Saraswathy S, Crawford FW, Lamborn KR, Pirzkall
A, Chang S, Cha S, Nelson SJ.
Evaluation of MR markers that predict survival in patients with newly
diagnosed GBM prior to adjuvant therapy
J Neurooncol. 2008 Sep 23; [Epub ahead of print]
Abstract
|
|
|
Schaich M, Kestel L, Pfirrmann M, Robel K,
Illmer T, Kramer M, Dill C, Ehninger G, Schackert G, Krex D.
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of
temozolomide treatment in glioblastoma patients
Ann Oncol. 2008 Aug 7; [Epub ahead of print]
Abstract
|
|
|
Scheurer ME, Amirian E, Cao Y, Gilbert MR,
Aldape KD, Kornguth DG, El-Zein R, Bondy ML
Polymorphisms in the interleukin-4 receptor gene are associated with
better survival in patients with glioblastoma
Clin Cancer Res. 2008 Oct 15;14(20):6640-6
Abstract
|
|
|
Schoenegger
K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D, Heinzl H,
Lahrmann H, Marosi C, Grisold W.
Peritumoral edema on MRI at initial diagnosis: an independent prognostic
factor for glioblastoma?
Eur J Neurol. 2009 Apr 10;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA,
Hamilton M, Cairncross JG, Forsyth P
Which
glioblastoma multiforme patient will become a long-term survivor? A
population-based study
Ann Neurol. 1999 Aug;46(2):183-8
|
|
Scott JN,
Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, Sutherland G,
Cairncross JG, Forsyth P
Long-term
glioblastoma multiforme survivors: a population-based study
Can J Neurol Sci. 1998 Aug;25(3):197-201
|
|
|
Senger
D, Cairncross JG, Forsyth PA
Long-term survivors of glioblastoma: statistical aberration or important
unrecognized molecular subtype?
Cancer J.
2003 May-Jun;9(3):214-21
Abstract
|
|
A.
Shet, A. E. Schorer, M. A. Kuskowski
Venous
thromboembolism is common but does not alter survival in glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
432
|
|
Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada
K, Kuratsu J, Ishimaru Y, Ushio Y
The influence of sex and the presence of giant cells on
postoperative long-term survival in adult patients with supratentorial
glioblastoma multiforme
J Neurosurg. 2004 Aug;101(2):219-26
|
|
|
Shirai K, Suzuki Y, Oka K, Noda SE, Katoh H,
Suzuki Y, Itoh J, Itoh H, Ishiuchi S, Sakurai H, Hasegawa M, Nakano T
Nuclear survivin expression predicts poorer prognosis in glioblastoma
J Neurooncol.
2008 Oct 25. [Epub ahead of print]
Abstract
|
|
|
Shnaper S, Desbaillets I, Brown DA, Murat A,
Migliavacca E, Schluep M, Ostermann S, Hamou MF, Stupp R, Breit SN, de
Tribolet N, Hegi ME
Elevated
levels of MIC-1/ GDF15 in the cerebro-spinal fluid (CSF) of patients are
associated with glioblastoma and worse outcome
Int
J Cancer. 2009 Jun 11. [Epub ahead of print]
Abstract
|
|
Simon, Matthias M.D.; Ludwig, Michael Ph.D.; Fimmers, Rolf Ph.D.; Mahlberg,
Ralph; Muller-Erkwoh, Angelika M.D.; Koster, Gertraud Ph.D.; Schramm, Johannes
M.D.
Variant Of The Chek2 Gene As A Prognostic Marker In Glioblastoma Multiforme.
Clinicopathological Study
Neurosurgery. 2006 Sep 28; [Epub ahead of
print]
Abstract
|
|
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P,
Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, et al
Influence of location and
extent of surgical resection on survival of patients with glioblastoma
multiforme: results of three consecutive Radiation Therapy Oncology Group
(RTOG) clinical trials
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44
|
|
|
Sorensen AG, Batchelor TT, Zhang WT, Chen PJ,
Yeo P, Wang M, Jennings D, Wen PY, Lahdenranta J, Ancukiewicz M, di Tomaso
E, Duda DG, Jain RK
A
"vascular normalization index" as potential mechanistic biomarker
to predict survival after a single dose of cediranib in recurrent
glioblastoma patients
Cancer Res. 2009
Jul 1;69(13):5296-300. Epub 2009 Jun 23
Abstract
|
|
|
Spence
AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC,
Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA.
Regional Hypoxia in Glioblastoma Multiforme Quantified with
[18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy:
Correlation with Time to Progression and Survival
Clin
Cancer Res. 2008 May 1;14(9):2623-30
Abstract
|
|
|
Sperduto
CM, Chakravarti A, Aldape K, Burger P, Papermaster GB, Sperduto P.
Twenty-Year Survival In Glioblastoma: A Case Report And Molecular Profile
Int J Radiat Oncol Biol Phys. 2009 Mar 25. [Epub ahead of print]°
Abstract
|
|
|
Stupp
R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK,
Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C,
Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller
M, Lacombe D, Cairncross JG, Mirimanoff RO
Effects of radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised phase III
study: 5-year analysis of the EORTC-NCIC trial
Lancet Oncol. 2009 Mar 6;. [Epub ahead of print]°
Abstract
|
|
|
Swanson KR, Rostomily RC, Alvord EC Jr
A mathematical modelling tool for predicting survival of individual
patients following resection of glioblastoma: a proof of principle
Br J Cancer. 2007 Dec 4;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
|
|
Tibbetts
KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR.
Histopathologic predictors of pilocytic astrocytoma event-free survival
Acta Neuropathol. 2009 Mar 7;. [Epub ahead of print]
Abstract
|
|
|
Tugcu
B, Postalci LS, Gunaldi O, Tanriverdi O, Akdemir H.
Efficacy of clinical prognostic factors on survival in patients with
glioblastoma
Turk Neurosurg. 2010 Apr;20(2):117-25
Abstract |
Reprint
|
|
|
Tramacere
F, Gianicolo E, Serinelli M, Bambace S, De Luca M, Castagna R, Francavilla
MC, Leone A, Monastero S, Fucilli F, Pili G, Distante A, Portaluri M.
Multivariate analysis of prognostic factors and survival inpatients with
"glioblastoma multiforme"
Clin Ter. 2008 Jul-Aug;159(4):233-238
Abstract
|
|
|
Wang LF, Fokas E, Juricko J, You A, Rose F,
Pagenstecher A, Engenhart-Cabillic R, An HX.
Increased expression of EphA7 correlates with adverse outcome in primary
and recurrent glioblastoma multiforme patients
BMC Cancer. 2008 Mar 25;8(1):79
Abstract |
Full Text |
Reprint
|
|
|
Welsh JW, Ellsworth RK, Kumar R, Fjerstad K,
Martinez J, Nagel RB, Eschbacher J, Stea B
Rad51
protein expression and survival in patients with glioblastoma multiforme
Int
J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1251-5
Abstract
|
|
|
Young GS, Macklin EA, Setayesh K, Lawson JD, Wen PY, Norden AD, Drappatz J,
Kesari S.
Longitudinal
MRI evidence for decreased survival among periventricular glioblastoma.
J
Neurooncol. 2010 Dec 5. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
Age
|
|
|
|
Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L,
Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP.
Age
as an independent prognostic factor in patients with glioblastoma: a
radiation therapy oncology group and American College of Surgeons National
Cancer Data Base comparison.
J
Neurooncol. 2011 Jan 9. [Epub ahead of print]
Abstract |
Related articles
|
|
Comparison
|
|
|
|
Tran B, Rosenthal MA.
Survival
comparison between glioblastoma multiforme and other incurable cancers.
J
Clin Neurosci. 2010 Apr;17(4):417-21. Epub 2010 Feb 18.
Abstract |
Related articles
|
|
Cystic
Glioblastoma
|
|
|
|
Kaur G, Bloch O, Jian BJ, Kaur R, Sughrue ME, Aghi MK, McDermott MW, Berger
MS, Chang SM, Parsa AT.
A
critical evaluation of cystic features in primary glioblastoma as a
prognostic factor for survival.
J Neurosurg. 2011
Jul 15. [Epub ahead of print]
Abstract |
Related articles
|
|
Conditional
Probability
|
|
|
|
Polley
MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M.
Conditional Probability of
Survival in Patients With Newly Diagnosed Glioblastoma.
J Clin Oncol. 2011
Oct 3;. [Epub ahead of print]
Abstract |
Related articles
|
|
Elderly
patients
|
|
|
|
Chaichana
KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, Quiñones-Hinojosa A.
Surgical outcomes for older patients with glioblastoma multiforme:
preoperative factors associated with decreased survival.
J Neurosurg. 2010 Oct 1;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Minniti
G, Salvati M, Arcella A, Buttarelli F, D'Elia A, Lanzetta G, Esposito V,
Scarpino S, Maurizi Enrici R, Giangaspero F
Correlation
between O(6)-methylguanine-DNA methyltransferase and survival in elderly
patients with glioblastoma treated with radiotherapy plus concomitant and
adjuvant temozolomide
J
Neurooncol. 2010 Aug 5. [Epub ahead of print]
Abstract
|
|
|
Shikama
N, Sasaki S, Shinoda A, Koiwai K.
Treatment
Outcome of Elderly Patients With Glioblastoma who Received Combination
Therapy.
Am
J Clin Oncol. 2011 May 20. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Zachenhofer I, Maier R, Eiter H, Muxel B, Cejna M, Devries A, Roessler K.
Overall
survival and extent of surgery in adult versus elderly glioblastoma patients:
A population based retrospective study.
Wien Klin
Wochenschr. 2011 May 18. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Genetic
Alterations
|
|
|
|
|
Kakkar A, Suri V, Jha P, Srivastava A, Sharma V, Pathak P, Sharma MC, Sharma
MS, Kale SS, Chosdol K, Phalak M, Sarkar C.
Loss of heterozygosity on chromosome 10q in glioblastomas, and its
association with other genetic alterations and survival in Indian patients.
Neurol India 2011;59:254-261. Epub 2011 Apr 7.
Abstract |
Full
text
|
|
|
Metellus
P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina
F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D.
Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients
Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at
a Single Institution.
Ann Surg Oncol. 2011 Apr 9;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Thon
N, Eigenbrod S, Grasbon-Frodl EM, Lutz J, Kreth S, Popperl G, Belka C,
Kretzschmar HA, Tonn JC, Kreth FW.
Predominant influence of MGMT methylation in non-resectable glioblastoma
after radiotherapy plus temozolomide
J Neurol Neurosurg Psychiatry. 2010 Sep 22;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Watanabe
R, Nakasu Y, Tashiro H, Mitsuya K, Ito I, Nakasu S, Nakajima T.
O(6)-Methylguanine DNA methyltransferase expression in tumor cells predicts
outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy
in patients with primary glioblastoma.
Brain Tumor Pathol. 2011 Feb 18;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Infection
|
|
|
|
|
De
Bonis P, M D AA, M D GL, de Waure C, Mangiola A, Pettorini BL, Pompucci A,
Balducci M, Fiorentino A, Lauriola L, Anile C, Maira G.
Post-operative infection may
influence survival in patients with glioblastoma: simply a myth?:
Glioblastoma, infection and survival.
Neurosurgery. 2011 May 5;. [Epub
ahead of print]
Abstract |
Related articles
|
|
Long
term survival
|
|
|
|
Deb
P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C.
Glioblastoma multiforme with long term survival.
Neurol India.
2005 Sep;53(3):329-32.
Abstract |
Full Text |
Related articles
|
|
Pediatric
|
|
|
|
Song
KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, Kim IH, Ahn HS, Park SH, Kim SK
Long-term outcomes in children with glioblastoma
J Neurosurg Pediatr. 2010 Aug;6(2):145-9
Abstract
|
|
Recurrent
Tumors
|
|
|
|
Murakami
R, Hirai T, Nakamura H, Furusawa M, Nakaguchi Y, Uetani H, Kitajima M,
Yamashita Y.
Recurrence patterns of
glioblastoma treated with postoperative radiation therapy: relationship
between extent of resection and progression-free interval.
Jpn J Radiol. 2011 Dec 20;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Park
JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N,
Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM
Scale to Predict Survival After Surgery for Recurrent Glioblastoma
Multiforme
J Clin Oncol. 2010 Jul 19;. [Epub ahead of print]
Abstract
|
|
|
Paulsson
J, Lindh MB, Jarvius M, Puputti M, Nistér M, Nupponen NN, Paulus W, Söderberg
O, Dresemann G, von Deimling A, Joensuu H, Ostman A, Hasselblatt M.
Prognostic but not predictive role of platelet-derived growth factor
receptors in patients with recurrent glioblastoma
Int J Cancer. 2010 Jun 29;. [Epub ahead of print]
Abstract
|
|
|
Xu T, Chen J, Lu Y.
Recurrent Glioblastoma: Not Only Surgery.
J
Clin Oncol. 2010 Dec 20. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
Resection
|
|
|
|
Allahdini
F, Amirjamshidi A, Reza-Zarei M, Abdollahi M
Evaluating the prognostic factors effective on the outcome of patients with
glioblastoma multiformis: does maximal resection of the tumor lengthen the
median survival?
World Neurosurg. 2010 Feb;73(2):128-34
Abstract |
Full Text |
Reprint |
Related articles
|
|
Serum
|
|
|
|
Borg
N, Guilfoyle MR, Greenberg DC, Watts C, Thomson S.
Serum albumin and survival in glioblastoma multiforme.
J Neurooncol. 2011 Mar 16;. [Epub ahead of print]
Abstract |
Related articles
|
|
Stem
Cells
|
|
|
|
Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S, Lee MC.
The presence of stem cell marker-expressing cells is not prognostically
significant in glioblastomas.
Neuropathology. 2011 Jan 27;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Pallini
R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F,
Martini M, De Maria R, Larocca LM
Expression
of the stem cell marker CD133 in recurrent glioblastoma and its value for
prognosis
Cancer. 2010 Aug
30. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Pallini R, Ricci-Vitiani L, Banna GL, Signore M,
Lombardi D, Todaro M, Stassi G, Martini M, Maira G, Larocca LM, De Maria R
Cancer
stem cell analysis and clinical outcome in patients with glioblastoma
multiforme
Clin
Cancer Res. 2008 Dec 15;14(24):8205-12
Abstract
|
|
Surgery
|
|
|
|
Sanai
N, Polley MY, McDermott MW, Parsa AT, Berger MS.
An extent of resection threshold for newly diagnosed glioblastomas.
J Neurosurg. 2011 Mar 18;. [Epub ahead of print]
Abstract |
Related articles
|
|
Temozolomide
|
|
|
|
Robinson
CG, Palomo JM, Rahmathulla G, McGraw M, Donze J, Liu L, Vogelbaum MA.
Effect of alternative temozolomide schedules on glioblastoma O(6)-methylguanine-DNA
methyltransferase activity and survival
Br J Cancer. 2010 Jul 13;. [Epub ahead of print]
Abstract
|
|
Valproic Acid
|
|
|
|
Tsai
HC, Wei KC, Tsai CN, Huang YC, Chen PY, Chen SM, Lu YJ, Lee ST.
Effect of valproic acid on the
outcome of glioblastoma multiforme.
Br J Neurosurg. 2011
Dec 15;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliosarcoma
|
|
|
|
|
Galanis
E, Buckner JC, Dinapoli RP, Scheithauer BW, Jenkins RB, Wang CH, O'Fallon
JR, Farr G Jr
Clinical outcome of gliosarcoma compared with glioblastoma multiforme:
North Central Cancer Treatment Group results
J Neurosurg. 1998
Sep;89(3):425-30
Abstract
|
|
|
Han
SJ, Yang I, Ahn BJ, Otero JJ, Tihan T, McDermott MW, Berger MS, Prados MD,
Parsa AT.
Clinical characteristics and outcomes for a modern series of primary
gliosarcoma patients
Cancer. 2010 Jan 5;. [Epub ahead of print]
Abstract
|
|
